Acyclovir resistance in herpes simplex virus isolates from keratitis cases: An analysis from a developing country

Microbiology and Immunology

Volumn 44, Issue 4, 2000, Pages 241-247

  Pramod, Naranatt Padmanabhan ^a   Thyagarajan, Sadras Panchatcharam ^a   Mohan, Keta Venkata Krishna ^a   Anandakannan, Kanagasabai ^b  

^a UNIVERSITY OF MADRAS   (India)

^b Regional Institute of Ophthalmology   (India)

Author keywords

Acyclovir resistance; Herpes simplex virus; Polymerase chain reaction; Single strand confirmation polymorphism

Indexed keywords

ACICLOVIR; THYMIDINE KINASE;

ANTIBIOTIC RESISTANCE; ARTICLE; ENZYME ASSAY; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; VIRUS CULTURE; VIRUS ISOLATION;

DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 0343527924     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2000.tb02490.x     Document Type: Article

References (31)

1. Bulasubramaniam, N.K., Veerisetty, V., and Gentry, G.A. 1990. Herpesviral deoxythymidine kinases contain a site analogous to the phosphoryl-binding arginine-rich region of porcine adenylate kinase; comparison of secondary-structure predictions and conservation. J. Gen. Virol. 71 (Pt12): 2979-2987.
2. Charles, S.J., and Gray, J.J. 1990. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease. Br. J. Ophthalmol. 74: 286-288.
3. Chatis, P.A., and Crumpacker, C.S. 1991. Analysis of the thymidine kinase gene from clinically isolated acyclovirresistant herpes simplex viruses. Virology 180: 793-797.
4. Collum, L.M.T., O'Connor, M., and Logan, P. 1983. Comparison of the efficacy and toxicity of acyclovir and of adenine arabinoside when combined with dilute betamethasone in herpetic disciform keratitis: preliminary results of a double-blind trial. Trans. Ophthalmol. Soc. U.K. 103: 597-599.
5. Ellis, M.N., Waters, R., Hill, E.L., Lobe, D.C., Selleseth, D.W., and Barry, D.W. 1989. Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1. Antimicrob. Agents Chemother. 33: 304-310.
6. Engel, J.P., Englund, J.A., Fletcher, C.V., and Hill, E.L. 1990. Treatment of resistant herpes simplex virus with continuous infusion acyclovir. JAMA 263: 1662-1664.
7. Englund, J.A., Zimmermun, M.E., Swierkosz, E.M., Goodman, J.L., Scholl, D.R., and Balfour, H.H., Jr. 1990. Herpes simplex virus resistant to acyclovir. A study in a tertiary care centre. Ann. Intern. Med. 112: 416-422.
8. Evans, J.S., Lock, K.P., Levine, B.A., Champness, J.N., Sanderson, M.R., Summers. W.C., McLeish, P.J., and Buchan, A. 1998. Herpesviral thymidine kinases: laxity and resistance by design. J. Gen. Virol. 79 (Pt9): 2083-2092.
9. Gateley, A., Gander, R.M., Johnson, P.C., Kit, S., Otsuka, H., and Kohl, S. 1990. Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS. J. Infect. Dis. 161:711-715.
10. Gaudreau, A., Hill, E., Balfour, H.H., Jr., Erice. A., and Boivin, G. 1998. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J. Infect. Dis. 178: 297-303.
11. Gray, J.J., Wreghitt, T.G., and Baglin, T. 1989. Susceptibility to acyclovir of herpes simplex virus: emergence of resistance in patients with lymphoid and myeloid neoplasia. J. Infect. 19:31-40.
12. Herpetic Eye Disease Study Group. 1998. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N. Engl. J. Med. 339: 300-306.
13. Hwang, C.B.C., Horsburh, B., Pelosi, E., Roberts. S., Digard, P., and Coen, D.M. 1994. A net + 1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant. Proc. Natl. Acad. Sci. U.S.A. 91: 5461-5466.
14. Kudo, E., Shiota, S., Naito, T., Satake, K., and Itakura, M. 1998. Polymorphisms of thymidine kinase gene in herpes simplex virus type 1 : analysis of clinical isolates from herpetic keratitis patients and laboratory strains. J. Med. Virol. 56: 151-158.
15. McGeoch, D.J., Dalrymple, M.A., Davison, A.J., Dolan, A., Frame, M.C., McNab, D., Perry, L.J., Scott, J.E., and Taylor, P. 1988. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 86 (Pt7): 1531-1574.
16. McGill, J.I., and Tormey, P. 1982. Use of acyclovir in herpetic ocular infection. Am. J. Med. 20: 286-289.
17. McKnight, S.L., and Kingsbury, R. 1982. Transcriptional control signals of a eukaryotic protein coding gene. Science 217: 316-324.
18. Menage, M.J., De Clercq, E., Van Lierde, A., Easty, V.S., Darville, J.M., Cook, S.D., and Easty, D.L. 1990. Antiviral drug sensitivity in ocular herpes simplex virus infection. Br. J. Ophihalmol. 74: 532-535.
19. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K. 1989. Rapid and sensitive detection of point mutations and DNA polymorphism using the polymerase chain reaction. Genomics 5: 874-879.
20. Pramod, N.P., Gopalakrishnan, V., Mohan, R., Chandriga, S., Anandakannan, K., and Thyagarajan, S.P. 1998. Enhanced detection of HSV from ocular specimens of herpetic keratitis patients. Ind. J. Pathol. Microbiol. 41: 49-53.
21. Pramod, N.P., Rajendran, P., Anandakannan, K., and Thyagarajan, S.P. 1999. Herpes simplex keratitis in South India: clinico-virological correlation. Jpn. J. Ophthalmol. 43: 303-307.
22. Safrin, S., Crumpacker, C., Chads, P., Davis, R., Hafner, R., Rush, J., Kessler, H.A., Landry, B., and Mills, J. 1991. A controlled trial comparing foscarnet therapy with vidarabine toracyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N. Engl. J. Med. 325:551-555.
23. Sasadeusz, J.J., and Sacks, S.L. 1996. Spontaneous reactivation of thymidine kinase-deficient, acyclovir-resistant type 2 herpes simplex virus infection: masked heterogeneity or reversion? J. Infect. Dis. 174: 476-482.
24. Sasadeusz, J.J., Tufaro, F., Safrin, S., Schubert, K., Hubinette, M.M., Cheung, P.K., and Sacks, S.L. 1997. Homopolymer mututional hotspots mediates herpes simplex virus resistance to acyclovir. J. Virol. 71: 3872-3878.
25. Shiota, H., Kudo, E., Mimura, Y., and Utakura, M. 1996. Mutation of the thymidine kinase gene in a Ganciclovirresistant strain of herpes simplex virus type 1 detected by PCR-SSCP and PCR-direct sequencing. Biomed. Res. 17: 9-14.
26. Sibrack, C.D., Gutman, L.T., Wilfert, C.M., McLaren, C., StChair, M.H., Keller, P.M., and Barry, D.W. 1982. Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child. J. Infect. Dis. 146: 673-682.
27. Sonkin, P.L., Baratz, K.H., Frothingham, R., and Cobo, L.M. 1992. Acyclovir resistant herpes simplex virus keratouveitis after penetrating keratoplasty. Ophthalmology 99: 1805-1808.
28. Summers, W.P., Wanger, M., and Summers, W.C. 1975. Possible peptide chain termination mutants in thymidine kinase gene of mammalian virus, herpes simplex virus. Proc. Natl. Acad. Sci. U.S.A. 72: 4081-4084.
29. Wade, J.C., McLaren, C., and Meyers, J.D. 1983. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir. J. Infect. Dis. 148: 1077-1082.
30. Wilber, B.A., and Docherty, J.J. 1994. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine. J. Gen. Virol. 75 (Pt7): 1743-1747.
31. Wilhelmus, K.R. 1987. Diagnosis and management of herpes simplex keratitis stromal keratitis. Cornea 6: 286-291.